444 related articles for article (PubMed ID: 21883674)
1. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
[TBL] [Abstract][Full Text] [Related]
2. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
[TBL] [Abstract][Full Text] [Related]
3. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients.
Koczulla AR; Noeske S; Herr C; Koepke J; Jörres RA; Nell C; Schmid S; Vogelmeier C; Bals R
Respir Med; 2012 Jan; 106(1):120-6. PubMed ID: 21872457
[TBL] [Abstract][Full Text] [Related]
6. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
[TBL] [Abstract][Full Text] [Related]
7. An electronic nose in the discrimination of patients with asthma and controls.
Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ
J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592
[TBL] [Abstract][Full Text] [Related]
8. Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ragnoli B; Radaeli A
J Intern Med; 2009 Mar; 265(3):382-7. PubMed ID: 19019191
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
10. Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations.
Shafiek H; Fiorentino F; Merino JL; López C; Oliver A; Segura J; de Paul I; Sibila O; Agustí A; Cosío BG
PLoS One; 2015; 10(9):e0135199. PubMed ID: 26353114
[TBL] [Abstract][Full Text] [Related]
11. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
[TBL] [Abstract][Full Text] [Related]
12. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
13. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
[TBL] [Abstract][Full Text] [Related]
14. A breath test for malignant mesothelioma using an electronic nose.
Chapman EA; Thomas PS; Stone E; Lewis C; Yates DH
Eur Respir J; 2012 Aug; 40(2):448-54. PubMed ID: 22183490
[TBL] [Abstract][Full Text] [Related]
15. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
16. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
17. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
18. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
[TBL] [Abstract][Full Text] [Related]
19. Detection of obstructive sleep apnoea by an electronic nose.
Greulich T; Hattesohl A; Grabisch A; Koepke J; Schmid S; Noeske S; Nell C; Wencker M; Jörres RA; Vogelmeier CF; Köhler U; Koczulla AR
Eur Respir J; 2013 Jul; 42(1):145-55. PubMed ID: 23100503
[TBL] [Abstract][Full Text] [Related]
20. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
